Aphasia, Broca: Clinical Trials

2 trials for Aphasia, Broca, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow Aphasia, Broca: new trials by email Literature Review of Aphasia, Broca trials Research Report on Aphasia, Broca

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Speech Entrainment for Aphasia Recovery
SET (Speech Entrainment Therapy) 3 weeks, SET (Speech Entrainment Therapy) 4.5 weeks, SET (Speech Entrainment Therapy) 6 weeks - Aphasia, Aphasia Non Fluent
Phase 2CompletedMedical University of South Carolina802020-08-212025-11-14
Augmenting Language Therapy for Aphasia: Levodopa
levodopa/carbidopa, Placebo comparator - Nonfluent Aphasia, Stroke
Phase 2 / Phase 3CompletedShirley Ryan AbilityLab362007-10-012013-12-25

Narrower conditions

Aphasia (2)  ·  Stroke (2)  ·  Ischemic Stroke (1)

Broader conditions

Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Communication Disorders (2)  ·  Language Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Speech Disorders (2)  ·  Vascular Diseases (2)

Interventions

SET protein, human (1)  ·  carbidopa, levodopa drug combination (1)

Sponsors

Medical University of South Carolina (1)  ·  Shirley Ryan AbilityLab (1)

Countries

United States (2)

Top investigators

Leonardo Bonilha, MD, PhD (1)

NIH funding

U01DC017521 (1)